Asset Management
Compare Stocks
4 / 10Stock Comparison
MRCC vs CSWC vs ARCC vs GAIN
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
MRCC vs CSWC vs ARCC vs GAIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Asset Management | Asset Management |
| Market Cap | $110M | $1.43B | $13.61B | $657M |
| Revenue (TTM) | $21M | $164M | $3.15B | $90M |
| Net Income (TTM) | $-5M | $103M | $1.15B | $130M |
| Gross Margin | 60.8% | 66.5% | 75.7% | 68.6% |
| Operating Margin | 51.7% | 48.5% | 69.7% | 72.7% |
| Forward P/E | 14.9x | 10.0x | 9.9x | 41.0x |
| Total Debt | $191M | $956M | $15.99B | $456M |
| Cash & Equiv. | $2M | $43M | $924M | $14M |
MRCC vs CSWC vs ARCC vs GAIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | Apr 26 | Return |
|---|---|---|---|
| Monroe Capital Corp… (MRCC) | 100 | 65.4 | -34.6% |
| Capital Southwest C… (CSWC) | 100 | 158.2 | +58.2% |
| Ares Capital Corpor… (ARCC) | 100 | 122.0 | +22.0% |
| Gladstone Investmen… (GAIN) | 100 | 128.0 | +28.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MRCC vs CSWC vs ARCC vs GAIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MRCC is the clearest fit if your priority is valuation efficiency.
- PEG 0.32 vs ARCC's 0.97
- Lower P/E (14.9x vs 41.0x)
CSWC is the #2 pick in this set and the best alternative if income & stability and bank quality is your priority.
- Dividend streak 3 yrs, beta 0.84, yield 10.2%
- NIM 7.0% vs ARCC's 3.6%
- 10.2% yield, 3-year raise streak, vs GAIN's 10.0%
- +34.0% vs MRCC's -6.8%
ARCC carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 32.9%, EPS growth -23.8%
- 32.9% NII/revenue growth vs MRCC's -39.7%
- Efficiency ratio 0.1% vs CSWC's 0.2% (lower = leaner)
- Efficiency ratio 0.1% vs CSWC's 0.2%
GAIN is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 319.3% 10Y total return vs CSWC's 234.2%
- Lower volatility, beta 0.53, Low D/E 91.3%, current ratio 3.69x
- Beta 0.53, yield 10.0%, current ratio 3.69x
- Beta 0.53 vs CSWC's 0.84, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 32.9% NII/revenue growth vs MRCC's -39.7% | |
| Value | Lower P/E (14.9x vs 41.0x) | |
| Quality / Margins | Efficiency ratio 0.1% vs CSWC's 0.2% (lower = leaner) | |
| Stability / Safety | Beta 0.53 vs CSWC's 0.84, lower leverage | |
| Dividends | 10.2% yield, 3-year raise streak, vs GAIN's 10.0% | |
| Momentum (1Y) | +34.0% vs MRCC's -6.8% | |
| Efficiency (ROA) | Efficiency ratio 0.1% vs CSWC's 0.2% |
MRCC vs CSWC vs ARCC vs GAIN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GAIN leads in 1 of 6 categories
MRCC leads 1 • CSWC leads 1 • ARCC leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
GAIN leads this category, winning 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARCC is the larger business by revenue, generating $3.1B annually — 148.3x MRCC's $21M. GAIN is the more profitable business, keeping 72.7% of every revenue dollar as net income compared to ARCC's 41.3%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $21M | $164M | $3.1B | $90M |
| EBITDAEarnings before interest/tax | $11M | $142M | $2.0B | $58M |
| Net IncomeAfter-tax profit | -$5M | $103M | $1.1B | $130M |
| Free Cash FlowCash after capex | $25M | -$69M | $1.1B | -$82M |
| Gross MarginGross profit ÷ Revenue | +60.8% | +66.5% | +75.7% | +68.6% |
| Operating MarginEBIT ÷ Revenue | +51.7% | +48.5% | +69.7% | +72.7% |
| Net MarginNet income ÷ Revenue | +53.8% | +43.1% | +41.3% | +72.7% |
| FCF MarginFCF ÷ Revenue | +5.5% | -132.6% | +36.3% | +126.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -51.5% | +113.3% | -63.9% | +58.1% |
Valuation Metrics
MRCC leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 9.3x trailing earnings, GAIN trades at a 43% valuation discount to CSWC's 16.3x P/E. Adjusting for growth (PEG ratio), MRCC offers better value at 0.21x vs ARCC's 0.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $110M | $1.4B | $13.6B | $657M |
| Enterprise ValueMkt cap + debt − cash | $108M | $2.3B | $28.7B | $1.1B |
| Trailing P/EPrice ÷ TTM EPS | 9.58x | 16.32x | 10.19x | 9.28x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.94x | 10.01x | 9.94x | 41.03x |
| PEG RatioP/E ÷ EPS growth rate | 0.21x | — | 0.99x | — |
| EV / EBITDAEnterprise value multiple | — | 27.43x | 13.09x | 16.82x |
| Price / SalesMarket cap ÷ Revenue | 3.55x | 8.71x | 4.33x | 7.31x |
| Price / BookPrice ÷ Book value/share | 0.66x | 1.39x | 0.93x | 1.22x |
| Price / FCFMarket cap ÷ FCF | 0.95x | — | 11.92x | 5.77x |
Profitability & Efficiency
Evenly matched — MRCC and ARCC and GAIN each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
GAIN delivers a 21.9% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $-3 for MRCC. GAIN carries lower financial leverage with a 0.91x debt-to-equity ratio, signaling a more conservative balance sheet compared to MRCC's 1.15x. On the Piotroski fundamental quality scale (0–9), MRCC scores 6/9 vs CSWC's 1/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -2.9% | +10.3% | +8.1% | +21.9% |
| ROA (TTM)Return on assets | -1.3% | +4.8% | +3.8% | +10.5% |
| ROICReturn on invested capital | +2.0% | +3.5% | +5.7% | +5.3% |
| ROCEReturn on capital employed | +2.6% | +4.6% | +7.5% | +6.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 1 | 4 | 4 |
| Debt / EquityFinancial leverage | 1.15x | 1.08x | 1.12x | 0.91x |
| Net DebtTotal debt minus cash | $189M | $913M | $15.1B | $441M |
| Cash & Equiv.Liquid assets | $2M | $43M | $924M | $14M |
| Total DebtShort + long-term debt | $191M | $956M | $16.0B | $456M |
| Interest CoverageEBIT ÷ Interest expense | 0.69x | 2.91x | 2.98x | 1.58x |
Total Returns (Dividends Reinvested)
Evenly matched — CSWC and GAIN each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GAIN five years ago would be worth $17,205 today (with dividends reinvested), compared to $9,905 for MRCC. Over the past 12 months, CSWC leads with a +34.0% total return vs MRCC's -6.8%. The 3-year compound annual growth rate (CAGR) favors CSWC at 20.7% vs MRCC's 5.7% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -11.4% | +11.4% | -4.9% | +20.7% |
| 1-Year ReturnPast 12 months | -6.8% | +34.0% | +0.4% | +30.8% |
| 3-Year ReturnCumulative with dividends | +18.0% | +75.8% | +34.2% | +56.5% |
| 5-Year ReturnCumulative with dividends | -0.9% | +51.4% | +47.0% | +72.0% |
| 10-Year ReturnCumulative with dividends | +22.8% | +234.2% | +139.2% | +319.3% |
| CAGR (3Y)Annualised 3-year return | +5.7% | +20.7% | +10.3% | +16.1% |
Risk & Volatility
Evenly matched — CSWC and GAIN each lead in 1 of 2 comparable metrics.
Risk & Volatility
GAIN is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than CSWC's 0.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CSWC currently trades 98.2% from its 52-week high vs MRCC's 65.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.76x | 0.81x | 0.75x | 0.51x |
| 52-Week HighHighest price in past year | $7.76 | $24.43 | $23.42 | $17.14 |
| 52-Week LowLowest price in past year | $4.04 | $19.37 | $17.40 | $13.11 |
| % of 52W HighCurrent price vs 52-week peak | +65.5% | +98.2% | +81.0% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 50.4 | 63.7 | 56.7 | 69.9 |
| Avg Volume (50D)Average daily shares traded | 156K | 664K | 7.5M | 371K |
Analyst Outlook
CSWC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MRCC as "Hold", CSWC as "Buy", ARCC as "Buy", GAIN as "Hold". Consensus price targets imply 57.5% upside for MRCC (target: $8) vs -9.1% for GAIN (target: $15). For income investors, CSWC offers the higher dividend yield at 10.20% vs MRCC's 0.24%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $8.00 | $23.58 | $21.88 | $15.00 |
| # AnalystsCovering analysts | 11 | 10 | 32 | 7 |
| Dividend YieldAnnual dividend ÷ price | +0.2% | +10.2% | +2.0% | +10.0% |
| Dividend StreakConsecutive years of raises | 0 | 3 | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.93 | $2.45 | $0.38 | $1.66 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% |
GAIN leads in 1 of 6 categories (Income & Cash Flow). MRCC leads in 1 (Valuation Metrics). 3 tied.
MRCC vs CSWC vs ARCC vs GAIN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MRCC or CSWC or ARCC or GAIN a better buy right now?
For growth investors, Ares Capital Corporation (ARCC) is the stronger pick with 32.
9% revenue growth year-over-year, versus -39. 7% for Monroe Capital Corporation (MRCC). Gladstone Investment Corporation (GAIN) offers the better valuation at 9. 3x trailing P/E (41. 0x forward), making it the more compelling value choice. Analysts rate Capital Southwest Corporation (CSWC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MRCC or CSWC or ARCC or GAIN?
On trailing P/E, Gladstone Investment Corporation (GAIN) is the cheapest at 9.
3x versus Capital Southwest Corporation at 16. 3x. On forward P/E, Ares Capital Corporation is actually cheaper at 9. 9x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Monroe Capital Corporation wins at 0. 32x versus Ares Capital Corporation's 0. 97x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MRCC or CSWC or ARCC or GAIN?
Over the past 5 years, Gladstone Investment Corporation (GAIN) delivered a total return of +72.
0%, compared to -0. 9% for Monroe Capital Corporation (MRCC). Over 10 years, the gap is even starker: GAIN returned +321. 5% versus MRCC's +22. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MRCC or CSWC or ARCC or GAIN?
By beta (market sensitivity over 5 years), Gladstone Investment Corporation (GAIN) is the lower-risk stock at 0.
51β versus Capital Southwest Corporation's 0. 81β — meaning CSWC is approximately 60% more volatile than GAIN relative to the S&P 500. On balance sheet safety, Gladstone Investment Corporation (GAIN) carries a lower debt/equity ratio of 91% versus 115% for Monroe Capital Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — MRCC or CSWC or ARCC or GAIN?
By revenue growth (latest reported year), Ares Capital Corporation (ARCC) is pulling ahead at 32.
9% versus -39. 7% for Monroe Capital Corporation (MRCC). On earnings-per-share growth, the picture is similar: Monroe Capital Corporation grew EPS 17. 8% year-over-year, compared to -28. 3% for Capital Southwest Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MRCC or CSWC or ARCC or GAIN?
Gladstone Investment Corporation (GAIN) is the more profitable company, earning 72.
7% net margin versus 41. 3% for Ares Capital Corporation — meaning it keeps 72. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GAIN leads at 72. 7% versus 48. 5% for CSWC. At the gross margin level — before operating expenses — ARCC leads at 75. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MRCC or CSWC or ARCC or GAIN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Monroe Capital Corporation (MRCC) is the more undervalued stock at a PEG of 0. 32x versus Ares Capital Corporation's 0. 97x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Ares Capital Corporation (ARCC) trades at 9. 9x forward P/E versus 41. 0x for Gladstone Investment Corporation — 31. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MRCC: 57. 5% to $8. 00.
08Which pays a better dividend — MRCC or CSWC or ARCC or GAIN?
All stocks in this comparison pay dividends.
Capital Southwest Corporation (CSWC) offers the highest yield at 10. 2%, versus 0. 2% for Monroe Capital Corporation (MRCC).
09Is MRCC or CSWC or ARCC or GAIN better for a retirement portfolio?
For long-horizon retirement investors, Gladstone Investment Corporation (GAIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
51), 10. 0% yield, +321. 5% 10Y return). Both have compounded well over 10 years (GAIN: +321. 5%, MRCC: +22. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MRCC and CSWC and ARCC and GAIN?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MRCC is a small-cap deep-value stock; CSWC is a small-cap deep-value stock; ARCC is a mid-cap high-growth stock; GAIN is a small-cap deep-value stock. CSWC, ARCC, GAIN pay a dividend while MRCC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.